We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




CT-Equipped Ambulance Proves Vital for Early Treatment of Stroke Patients

By HospiMedica International staff writers
Posted on 12 Jun 2012
NeuroLogica Corporation (Danvers, MA, USA), a manufacturer of medical imaging equipment, and MEYTEC GmbH (MEYTEC; Werneuchen/Seefeld, Brandenburg, Germany), which specializes in telemedicine solutions, have announced the development of the world’s first comprehensive mobile stroke ambulance. More...


First conceived by the Charite-University Medicine Berlin, with the support of MEYTEC GmbH, the Stroke-Emergency-Mobile unit, VIMED STEMO, combines MEYTEC’s innovative telemedicine solutions with NeuroLogica’s state-of-the-art portable CT scanner, CereTom, a portable 8-slice CT scanner that delivers high-quality perfusion scans, allowing physicians onboard the ambulance to quickly evaluate, diagnose, and treat the patient within the first hour of stroke onset.

Utilizing 3G, 4G, and satellite technology, VIMED STEMO allows laboratory results, high-quality images, and care instruction to be transmitted to emergency rooms or trauma centers in real time, enabling patients to be treated faster as well as reducing possible disabilities resulting from stroke.

“With the technological solution realized in STEMO, we have got a fascinating mobile facility that has already proven its technological stability and clinical usefulness in hundreds of cases,” said Heinrich Audebert, professor, Charite-University Medicine and head, Stroke-Emergency-Mobile association. “Hyper-acute stroke care, including thrombolytic treatment before arrival at a hospital, has become reality in Berlin.”

David Webster, vice president, global sales and marketing, NeuroLogica, agrees that VIMED STEMO is critical for the early intervention and treatment of stroke.

“A large part of NeuroLogica’s vision is to deliver high quality imaging to people and places around the world that otherwise would not have access to this life saving technology,” said Mr. Webster. “The partnership between NeuroLogica and MEYTEC, resulting in the development of the comprehensive stroke ambulance, is a real-world fulfillment of that vision. NeuroLogica is delighted to be part of this groundbreaking advancement in rapid stroke diagnosis and treatment.”


Related Links:

NeuroLogica Corporation

MEYTEC GmbH



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.